Developing the analytical methods for the assay of anthelmintics (Albendazole) and anti- tuberculosis agents (Ethionamide) by utilizing two CT reagents - iodine and picric acid
Keywords:
anthelmintics, anti- tuberculosis, albendazole, ethionamide, iodine, picric acidAbstract
Introduction - Rifampin, isoniazid, pyrazinamide, and ethambutol are antitubercular drugs that have been licenced by the FDA for the treatment of Mycobacterium tuberculosis infections. Antitubercular medicines are drugs that are used to treat tuberculosis. The term "anthelmintic" refers to a medicine used to treat parasitic worm infestations in animals. This comprises both flat and round worms, such as flukes (trematodes) and tapeworms (cestodes) (nematodes). Aim of this study - The primary aim of this research is to develop and validate simple, fast, reliable, robustness and ruggedness analytical procedures for anthelmintics (ALB) and antitubercular (ETH) medicines. Material and Methods - Two CT reagents, iodine and picric acid, were used to produce two simple and somewhat sensitive Albendazole (ALB) and Ethionamide (ETN) techniques. The CT complex with the placebo blank had almost the same absorbance as the reagent blank, indicating that there was no interference by using Systronics model 166 digital spectrophotometer tools. Organic solvents were employed to dissolve all of the chemicals, which were of analytical reagent grade.
Downloads
References
Conterno, L. O., Turchi, M. D., Corrêa, I., & Monteiro de Barros Almeida, R. A. (2020). Anthelmintic drugs for treating ascariasis. The Cochrane database of systematic reviews, 4(4), CD010599. https://doi.org/10.1002/14651858.CD010599.pub2
Yan Lin, et al (2020) -Synthesis, characterization and antiparasitic activity of organometallic derivatives of the anthelmintic drug albendazole. Dalton Trans., 2020,49, 6616-6626
Patel, C., Hürlimann, E., Keller, L. et al. Efficacy and safety of ivermectin and albendazole co-administration in school-aged children and adults infected with Trichuris trichiura: study protocol for a multi-country randomized controlled double-blind trial. BMC Infect Dis 19, 262 (2019). https://doi.org/10.1186/s12879-019-3882-x
Patil, Yogesh & Darvekar, Kavita & Kher, J. & Deshpande, M.. (2017). Studies on development of antituberculosis agents. International Journal of Engineering and Technical Research. 4.
Scardigli, Anna & Caminero, Jose & Sotgiu, Giovanni & Centis, Rosella & D'Ambrosio, Lia & Migliori, Giovanni Battista. (2016). Efficacy and tolerability of ethionamide versus prothionamide: A systematic review. European Respiratory Journal. 48. ERJ-00438. 10.1183/13993003.00438-2016.
N. Swamy, K.N. Prashanth and K. Basavaiah, Analytical utility of potassium permanganate for the assay of albendazole in bulk drug and pharmaceuticals, J. Reports Pharm. Sci. 4(1), 2015, 12.
LCGC Editors, Emerging Trends in Pharmaceutical Analysis, LCGC on 17 March 18, 2015
Yadav, Piyush & Singh, Rupali. (2011). A review on anthelmintic drugs and their future scope. International Journal of Pharmacy and Pharmaceutical Sciences. 3. 17-21.
Deokate, Uday & Lahane, & Ahire, Sujeetkumar & Lahane-Ahire, Sandhya. (2020). Review on Anthelmintic Drugs. Pharma Research.
Kumar, Vicky & Junaid, Mohd & Kesri, Kuldeep & Kushawah, Deepak. (2020). INTRODUCTION OF TUBERCULOSIS DISEASE AND CLASSIFICATION OF ANTI TUBERCULOSIS DRUGS. 10.20959/wjpps20194-13496.
Bocanegra-Garci?a, Virgilio & Garci?a, Abraham & Palma-Nicolás, José & Palos, Isidro & Rivera, Gildardo. (2011). Antitubercular Drugs Development: Recent Advances in Selected Therapeutic Targets and Rational Drug Design. 10.5772/27735.
Dwivedi S, Mahor A, Chanchal D. Chitosan nanoparticles: A review. World J Pharm Pharm Sci. 2015 Nov 9; 5: 433-9.
Rashi S, Singh D, Chanchal DK, Singh M, Anand S, Alok S. Cubosomes: a bicontinuous cubic crystalline phase. International Journal of Life Sciences and Review. 2015; 1(10): 291-301.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
![Creative Commons License](http://i.creativecommons.org/l/by-nc-nd/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.